Merck KGaA

MRK: XETR (DEU)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
€347.00YlwvfqyTrbmsmgcrg

Merck KGaA Earnings: Raises 2024 Outlook Slightly, but No Fair Value Estimate Change

Narrow-moat Merck KGaA's second-quarter results looked strong, and management slightly raised its 2024 outlook on momentum in its healthcare and electronics segments. At first glance, mild changes to our assumptions do not materially affect our fair value estimate, though. Shares remain fairly valued.

Sponsor Center